Literature DB >> 32539614

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis.

Lili Zhang1,2, Daniel A Zlotoff2, Magid Awadalla1,2, Syed S Mahmood3, Anju Nohria4, Malek Z O Hassan1, Franck Thuny5,6, Leyre Zubiri7, Carol L Chen8, Ryan J Sullivan7, Raza M Alvi1, Adam Rokicki1, Sean P Murphy2, Maeve Jones-O'Connor2, Lucie M Heinzerling9, Ana Barac10, Brian J Forrestal10, Eric H Yang11, Dipti Gupta8, Michael C Kirchberger9, Sachin P Shah12, Muhammad A Rizvi13, Gagan Sahni14, Anant Mandawat15, Michael Mahmoudi16, Sarju Ganatra12, Stephane Ederhy17, Eduardo Zatarain-Nicolas18, John D Groarke4, Carlo G Tocchetti19, Alexander R Lyon20, Paaladinesh Thavendiranathan21, Justine V Cohen7, Kerry L Reynolds7, Michael G Fradley22, Tomas G Neilan1,2.   

Abstract

Entities:  

Keywords:  corticosteroid; immunotherapy; myocarditis

Year:  2020        PMID: 32539614      PMCID: PMC7301778          DOI: 10.1161/CIRCULATIONAHA.119.044703

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.

Authors:  Alida L P Caforio; Sabine Pankuweit; Eloisa Arbustini; Cristina Basso; Juan Gimeno-Blanes; Stephan B Felix; Michael Fu; Tiina Heliö; Stephane Heymans; Roland Jahns; Karin Klingel; Ales Linhart; Bernhard Maisch; William McKenna; Jens Mogensen; Yigal M Pinto; Arsen Ristic; Heinz-Peter Schultheiss; Hubert Seggewiss; Luigi Tavazzi; Gaetano Thiene; Ali Yilmaz; Philippe Charron; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-07-03       Impact factor: 29.983

2.  Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.

Authors:  Magid Awadalla; Syed S Mahmood; John D Groarke; Malek Z O Hassan; Anju Nohria; Adam Rokicki; Sean P Murphy; Nathaniel D Mercaldo; Lili Zhang; Daniel A Zlotoff; Kerry L Reynolds; Raza M Alvi; Dahlia Banerji; Shiying Liu; Lucie M Heinzerling; Maeve Jones-O'Connor; Rula B Bakar; Justine V Cohen; Michael C Kirchberger; Ryan J Sullivan; Dipti Gupta; Connor P Mulligan; Sachin P Shah; Sarju Ganatra; Muhammad A Rizvi; Gagan Sahni; Carlo G Tocchetti; Donald P Lawrence; Michael Mahmoudi; Richard B Devereux; Brian J Forrestal; Anant Mandawat; Alexander R Lyon; Carol L Chen; Ana Barac; Judy Hung; Paaladinesh Thavendiranathan; Michael H Picard; Franck Thuny; Stephane Ederhy; Michael G Fradley; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2020-02-11       Impact factor: 24.094

3.  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Julie R Brahmer; Christina Lacchetti; Bryan J Schneider; Michael B Atkins; Kelly J Brassil; Jeffrey M Caterino; Ian Chau; Marc S Ernstoff; Jennifer M Gardner; Pamela Ginex; Sigrun Hallmeyer; Jennifer Holter Chakrabarty; Natasha B Leighl; Jennifer S Mammen; David F McDermott; Aung Naing; Loretta J Nastoupil; Tanyanika Phillips; Laura D Porter; Igor Puzanov; Cristina A Reichner; Bianca D Santomasso; Carole Seigel; Alexander Spira; Maria E Suarez-Almazor; Yinghong Wang; Jeffrey S Weber; Jedd D Wolchok; John A Thompson
Journal:  J Clin Oncol       Date:  2018-02-14       Impact factor: 44.544

4.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

5.  Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Authors:  I Puzanov; A Diab; K Abdallah; C O Bingham; C Brogdon; R Dadu; L Hamad; S Kim; M E Lacouture; N R LeBoeuf; D Lenihan; C Onofrei; V Shannon; R Sharma; A W Silk; D Skondra; M E Suarez-Almazor; Y Wang; K Wiley; H L Kaufman; M S Ernstoff
Journal:  J Immunother Cancer       Date:  2017-11-21       Impact factor: 13.751

  5 in total
  47 in total

1.  A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer.

Authors:  Clara Faubry; Maxime Faure; Anne-Claire Toublanc; Rémi Veillon; Anne-Iris Lemaître; Charlotte Vergnenègre; Hubert Cochet; Sadia Khan; Chantal Raherison; Pierre Dos Santos; Maeva Zysman
Journal:  Front Cardiovasc Med       Date:  2022-06-06

2.  Temporal Trends and Outcomes Among Patients Admitted for Immune-Related Adverse Events: A Single-Center Retrospective Cohort Study from 2011 to 2018.

Authors:  Gabriel E Molina; Leyre Zubiri; Justine V Cohen; Sienna M Durbin; Laura Petrillo; Ian M Allen; Yonina R Murciano-Goroff; Michael Dougan; Molly F Thomas; Alexander T Faje; Michelle Rengarajan; Amanda C Guidon; Steven T Chen; Daniel Okin; Benjamin D Medoff; Mazen Nasrallah; Minna J Kohler; Sara R Schoenfeld; Rebecca S Karp Leaf; Meghan E Sise; Tomas G Neilan; Daniel A Zlotoff; Jocelyn R Farmer; Meghan J Mooradian; Aditya Bardia; Minh Mai; Ryan J Sullivan; Yevgeniy R Semenov; Alexandra Chloé Villani; Kerry L Reynolds
Journal:  Oncologist       Date:  2021-03-31

Review 3.  What the Cardiologist Needs to Know About Cancer Immunotherapies and Complications.

Authors:  Marina Frayberg; Anthony Yung; Leyre Zubiri; Daniel A Zlotoff; Kerry L Reynolds
Journal:  Curr Treat Options Oncol       Date:  2021-05-26

Review 4.  Immune checkpoint inhibitor-associated myocarditis: manifestations and mechanisms.

Authors:  Javid Moslehi; Andrew H Lichtman; Arlene H Sharpe; Lorenzo Galluzzi; Richard N Kitsis
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

5.  Response to Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque".

Authors:  Zsofia D Drobni; Thomas Mayrhofer; Udo Hoffmann; Tomas G Neilan
Journal:  Circulation       Date:  2021-06-21       Impact factor: 39.918

6.  Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque.

Authors:  Udo Hoffmann; Tomas G Neilan; Zsofia D Drobni; Raza M Alvi; Jana Taron; Amna Zafar; Sean P Murphy; Paula K Rambarat; Rayma C Mosarla; Charlotte Lee; Daniel A Zlotoff; Vineet K Raghu; Sarah E Hartmann; Hannah K Gilman; Jingyi Gong; Leyre Zubiri; Ryan J Sullivan; Kerry L Reynolds; Thomas Mayrhofer; Lili Zhang
Journal:  Circulation       Date:  2020-10-02       Impact factor: 29.690

7.  Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review.

Authors:  Shujing Liang; Jingxian Yang; Yun Lin; Tong Li; Wenrong Zhao; Jun Zhao; Chunyan Dong
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

8.  Pericardial disease in patients treated with immune checkpoint inhibitors.

Authors:  Jingyi Gong; Zsofia Dora Drobni; Amna Zafar; Thiago Quinaglia; Sarah Hartmann; Hannah K Gilman; Vineet K Raghu; Carlos Gongora; Meghan E Sise; Raza M Alvi; Leyre Zubiri; Anju Nohria; Ryan Sullivan; Kerry L Reynolds; Daniel Zlotoff; Tomas G Neilan
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

Review 9.  Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategies.

Authors:  Ryan J Sullivan; Jeffrey S Weber
Journal:  Nat Rev Drug Discov       Date:  2021-07-27       Impact factor: 112.288

10.  Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.

Authors:  Julie R Brahmer; Hamzah Abu-Sbeih; Paolo Antonio Ascierto; Jill Brufsky; Laura C Cappelli; Frank B Cortazar; David E Gerber; Lamya Hamad; Eric Hansen; Douglas B Johnson; Mario E Lacouture; Gregory A Masters; Jarushka Naidoo; Michele Nanni; Miguel-Angel Perales; Igor Puzanov; Bianca D Santomasso; Satish P Shanbhag; Rajeev Sharma; Dimitra Skondra; Jeffrey A Sosman; Michelle Turner; Marc S Ernstoff
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.